SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for SYROS PHARMACEUTICALS INC by Syros Pharmaceuticals, Inc. (SYRS).

Price Target Range — 4 Quarters

Analyst Consensus — 5 Analysts

1Buy

4Hold

Consensus RatingOverweight# Analysts5Avg. Consensus PT$3Upside to Avg. PT+9515.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 13, 2024	TD Cowen	Phil Nadeau	Downgrade	Buy→Hold	—
Nov 13, 2024	HC Wainwright & Co.	Andrew Fein	Downgrade	Buy→Neutral	$6→$1
Nov 13, 2024	JMP Securities	Jason Butler	Downgrade	Market Outperform→Market Perform	—
Nov 13, 2024	Brookline Capital	Leah Rush	Downgrade	Buy→Hold	—
Nov 1, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$6
Aug 13, 2024	JMP Securities	Jason Butler	PT Cut	Market Outperform	$12→$4
Aug 13, 2024	Piper Sandler	Edward Tenthoff	PT Cut	Overweight	$13→$5
Aug 13, 2024	HC Wainwright & Co.	Andrew Fein	PT Cut	Buy	$15→$6
Aug 1, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Jun 26, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
May 15, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Apr 3, 2024	Piper Sandler	Edward Tenthoff	Maintained	Overweight	$13
Apr 1, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Oct 3, 2023	Piper Sandler	Edward Tenthoff	PT Cut	Overweight	$11→$7